Integra Q3 Earnings, Revenues Beat, Stock Up Despite Margin Pressure

Integra LifeSciences Holdings Corporation (IART) delivered adjusted earnings per share (EPS) of 41 cents for the third quarter of 2024, a 46.1% plunge year over year. The metric, however, surpassed the Zacks Consensus Estimate by 5.1%.The adjustment excludes the impact of certain non-recurring charges like structural optimization charges, the Boston recall/Braintree transition and EU Medical Device Regulation charges among others.GAAP loss per share in the third quarter was 14 cents against GAAP EPS of 24 c ...